TIMP2 and acute kidney injury: However, biomarkers including urine NGAL and urine tissue inhibitor of metalloproteinase-2 (TIMP-2) didn’t predict the mortality among decompensated cirrhotic patients with AKI and patients with community-acquired AKI [42,43].